Drug intelligence / Profile preview

compound amino acid (20AA)

Development stage
Unknown
Lead developer
Changzhou Wujin People's Hospital
Modality
Small Molecules
Administration
Intravenous
01

Overview

Compound amino acid (20AA) is a parenteral nutrition solution containing a balanced mixture of 20 essential and non-essential amino acids, including branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine. It is designed to provide nutritional support, promote protein synthesis, and maintain nitrogen balance in patients with impaired oral intake or specific metabolic requirements. In clinical research, particularly in China, it is being investigated for its potential neuroprotective and metabolic support roles in Amyotrophic Lateral Sclerosis (ALS), often in combination with other agents like high-dose Vitamin B6. The 20AA formulation typically includes amino acids such as L-ornithine and L-citrulline in addition to the standard proteinogenic amino acids, which may assist in ammonia detoxification and urea cycle function.

Brand names
Amino Acid Injection (20AA)
Other names
20AA compound amino acid injectioncompound amino acid injection (20AA)
02

Targets

SERPINA1 (Alpha-1-antitrypsin)Ribosome

Beyond the preview

Go deeper on compound amino acid (20AA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound amino acid (20AA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call